SWX:SDZPharmaceuticals
Is Sandoz (SWX:SDZ) Building a Durable Edge With Its New Slovenian Biosimilar Hub?
Sandoz Group AG has opened a fully digitally integrated, US$99 million biosimilar development centre in Ljubljana, Slovenia, spanning about 10,000 m² and employing more than 200 scientists as part of its plan to build an end-to-end European biosimilar hub.
The facility’s integration with sites in Germany, the UK, Slovenia and the recently acquired Toulouse, France, biosimilar plant highlights Sandoz’s push to bring more biosimilar development and manufacturing in-house across its European...